Time window for the contribution of the δ-opioid receptor to cardioprotection by ischemic preconditioning in the rat heart

Cardiovascular Drugs and Therapy

Volumn 12, Issue 4, 1998, Pages 365-373

  Tsuchida, Akihito ^a   Miura, Tetsuji ^a   Tanno, Masaya ^a   Nozawa, Yukinaga ^a   Kita, Hiroyuki ^a   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

receptor; Infarct size; Opioid; Preconditioning; Rat

Indexed keywords

DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE ANTAGONIST; TETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TIME;

ANIMALS; HEART; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; TIME FACTORS;

EID: 0031756094     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007720801004     Document Type: Article

References (32)

1. Liu GS, Thornton JD, Van Winkle DM, Stanley AWH, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in the rabbit heart. Circulation 1991;84:350-356.
2. Tsuchida A, Miura T, Miki T, Shimamoto K, Iimura O. Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning. Cardiovasc Res 1992;26:456-461.
3. ATP channel. Am J Physiol 1994;266:H829-839.
4. 1 adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5′-nucleotidase activity. J Clin Invest 1994;93:2197-2205.
5. Tanaka M, Fujiwara H, Yamasaki K, Sasayama S. Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate the infarct size-limiting effect of ischaemic preconditioning in the rabbit. Cardiovasc Res 1994;28:980-986.
6. Li Y, Kloner RA. The cardioprotective effects of ischemic "preconditioning" are not mediated by adenosine receptors in rat hearts. Circulation 1993;87:1642-1648.
7. Liu Y, Downey JM. Ischemic preconditioning protects against infarction in the rat heart. Am J Physiol 1992;263: H1107-H1112.
8. 1 receptor and protein kinase C in infarct size limitation by ischemic preconditioning in the rat heart (abstr). Circulation 1994;90:I-647.
9. Richard V, Tron C, Thuillez C. Ischaemic preconditioning is not mediated by oxygen-derived free radicals in rats. Cardiovasc Res 1993;27:2016-2021.
10. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C: Its role in ischemic preconditioning in the rat. Circ Res 1994;75:586-590.
11. Li Y, Kloner RA. Does protein kinase C play a role in ischemic preconditioning; in rat hearts? Am J Physiol 1995; 268:H426-H431.
12. Gross GJ, Schultz JJ. Glibenclamide abolishes ischemic preconditioning in a time-dependent manner in the rat heart (abstr). FASEB J 1996;10:A140.
13. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-233.
14. Ytrehus K, Liu Y, Downey JM. Preconditioning protects the ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266, H1145-1152.
15. Schultz JJ, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995;268:H2157-H2161.
16. Schultz JJ, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996; 78:1100-1104.
17. Wittert G, Hope P, Pyle D. Tissue distribution of opioid receptor gene expression in the rat. Biochem Biophys Res Commun 1996;218:877-881.
18. Portoghese PS, Sultana M, Takemori AE. Naltrindole, a highly selective and potent non-peptide 8 opioid receptor antagonist. Eur J Pharmacol 1988;146:185-186.
19. Muhammad BY, Kitchen I. Effect of delayed weaning on opioid receptor control of swim stress-induced antinociception in the developing rat. Br J Pharmacol 1993;109:651-654.
20. Negus SS, Henriksen SJ, Mattox A, et al. Effect of antagonist selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats. J Pharmacol Exp Ther 1993;265:1245-1252.
21. Takemori AE, Ho YH, Naeseth JS, Portoghese PS. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther 1988;246:255-258.
22. Takemori AE, Schwartz MM, Portoghese PS. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats. Pharmacol Exp Ther 1988;247:971-974.
23. Jeffe JH, Martin RM. Opioid analgesics and antagonists. In: Goodman, Gilman A, Rall TW, Nies AS, Taylor P (eds). The Pharmacological Basis of Therapeutics. New York: Pergamon Press, 1990:485-521.
24. Miki T, Sato H, Cohen MV, Downey JM. Opioid receptor contributes to ischemic preconditioning though protein kinase C activation in rabbits (abstr). Circulation 1996;94: I-392.
25. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Moll Cell Cardiol 1997;29: 207-216.
26. Miura T, Miura T, Kawamura S, et al. Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes. Cardiovasc Res, 1998;37:700-709.
27. Giugliano D, Cozzolino D, Salvatore T, et al. Physiological elevations of plasma beta-endorphin alter glucose metabolism in obese, but not normal-weight, subjects. Metabolism 1992;41:194-190.
28. Boluyt MO, Younes A, Caffrey JL, O'Neill L, Barron BA, Crow MT, Lakatta EG. Age-associated increase in rat cardiac opioid production. Am J Physiol 1993;265:H212-H218.
29. Denavit-Saubie M, Champagnat J, Zieglansberger W. Effects of opiates and methionine-enkephaline on pontine and bulbar respiratory neurones of the cat. Brain Res 1978;155: 57-67.
30. ATP channels during anoxia and ischemia. New Physiol Sci 1997;12:78-83.
31. + channels in heart muscle cells first open and subsequently close at maintained anoxia. FEBS Lett 1994;351:365-369.
32. Magnan J, Paterson SJ, Tavani A, Kosterlitz HW. The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn-Schmiedebergs Arch Phamacol 1982;319:197-205.